Literature DB >> 3259547

Early synergistic killing activity at concentrations attainable in CSF of amoxicillin or cefotaxime and aminoglycosides against Haemophilus influenzae.

E Bingen1, N Lambert-Zechovsky, Y Aujard, P Mariani, G Lemer, C Sauzeau, H Mathieu.   

Abstract

Rapid eradication of bacteria from the CSF is critical for the outcome of Haemophilus influenzae meningitis in children. In 15 patients studied, the mean H. influenzae colony counts in CSF were 10(5) CFU/ml (range: 10(2) to 10(9) CFU/ml). Time-kill curves were determined for amoxicillin and cefotaxime alone and in combination with gentamicin or amikacin, against 60 clinical isolates of H. influenzae at concentrations equivalent to those found in CSF following systemic administration. Against beta-lactamase-negative strains (n = 44) a bactericidal effect was observed at 18 h for amoxicillin alone, at 5 h for amoxicillin plus aminoglycosides and at 2.5 h for cefotaxime with or without aminoglycosides. Against beta-lactamase-positive strains a bactericidal effect was observed at 18 h for cefotaxime, at 5 h for amoxicillin plus aminoglycosides and at 2.5 h for cefotaxime plus aminoglycosides. It appears that despite low concentrations of gentamicin or amikacin in the CSF, the accelerated killing of H. influenzae provides a rationale for the initial use of the combination of cefotaxime and aminoglycosides in the initial treatment of H. influenzae meningitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259547     DOI: 10.1007/bf01644320

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.

Authors:  M S Simberkoff; N H Moldover; J Rahal
Journal:  J Lab Clin Med       Date:  1980-03

Review 2.  Antimicrobial penetration into cerebrospinal fluid.

Authors:  M L Richards; R A Prince; K A Kenaley; J A Johnson; J L LeFrock
Journal:  Drug Intell Clin Pharm       Date:  1981-05

3.  Antibiotic therapy of bacterial meningitis: lessons we've learned.

Authors:  M A Sande
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

4.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

5.  Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes.

Authors:  W M Scheld; D D Fletcher; F N Fink; M A Sande
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

6.  Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.

Authors:  H M Swingle; R L Bucciarelli; E M Ayoub
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

7.  In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.

Authors:  S Shelton; J D Nelson; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

8.  Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

Authors:  W E Feldman; C M Ginsburg; G H McCracken; D Allen; P Ahmann; J Graham; L Graham
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

9.  Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.

Authors:  R H Eng; C Cherubin; S M Smith; F Buccini
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

10.  Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis.

Authors:  G H McCracken; L D Sarff; M P Glode; S G Mize; M S Schiffer; J B Robbins; E C Gotschlich; I Orskov; F Orskov
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

View more
  3 in total

Review 1.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

2.  Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part II: Bacteriological results.

Authors:  P Hohl; E Martin; F H Kayser
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

3.  Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.

Authors:  J L Gaillard; C Silly; A Le Masne; B Mahut; F Lacaille; G Cheron; V Abadie; P Hubert; V Matha; C Coustere
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.